Patient preferences and inhaler use in chronic obstructive pulmonary disease

International Journal of Respiratory Care

Volumn 2, Issue 3, 2006, Pages 95-99

  Osman, Liesl M ^a,b  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b ABERDEEN ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE; CORTICOSTEROID; FLUTICASONE PROPIONATE; MONTELUKAST; OXYGEN; PLACEBO;

AEROSOL; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; COST BENEFIT ANALYSIS; DRUG EFFICACY; DRUG PREFERENCE; DRY POWDER; HEALTH CARE COST; HUMAN; INHALATION SPACER; INHALER; METERED DOSE INHALER; MONOTHERAPY; OXYGEN THERAPY; PATIENT COMPLIANCE; PSYCHOLOGICAL ASPECT; REVIEW; SMOKING CESSATION;

EID: 33750054385     PISSN: 17471273     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (24)

1. Lenney J, Innes JA, Crompton GK. Inappropriate inhaler use: assessment of use and patent preference of seven inhalation devices. EDICI. Respir Med 2000; 94: 496-500.
2. van Schayck CP, Bijl-Hofland ID, Folgering H et al. Influence of two different inhalaton devices on therapy compliance in asthmatic patients. Scand J Prim Health Care 2002; 20: 126-128.
3. Brennan VK, Osman LM, Graham H, Critchlow A, Everard ML. True device compliance: the need to consider both competence and contrivance. Respir Med 2005; 99: 97-102.
4. Lindberg M, Ekstrom T, Moller M, Ahlner J. Asthma care and factors affecting medication compliance: the patient's point of view. Int J Qual Health Care 2001; 13: 375-383.
5. Weinberger M, Murray MD, Marrero DG et al. Effectiveness of pharmacist care for patients with reactive airways disease: a randomized controlled trial. JAMA 2002; 288: 1594-1602.
6. Allen SC, Ragab S. Ability to learn inhaler technique in relation to cognitive scores and tests of praxis in old age. Postgrad Med J 2002; 78: 37-39.
7. Stempel DA, Stoloff SW, Carranza R Jr, Stanford RH, Ryskina KL, Legorreta AP. Adherence to asthma controller medication regimens. Respir Med 2005; 99: 1263-1267.
8. Onyirimba F, Apter A, Reisine S et al. Direct clinician-to-patient feedback discussion of inhaled steroid use: its effect on adherence. Ann Allergy/Asthma Immunol 2003; 90: 411-415.
9. Cote J, Bowie DM, Robichaud P, Parent JG, Battisti L, Boulet LP. Evaluation of two different educational interventions for adult patients consulting with an acute asthma exacerbation. Am J Respir Crit Care Med 2001; 163: 1415-1419.
10. Osman LM, Russell IT, Friend JA, Legge JS, Douglas JG. Predicting patient attitudes to asthma medication. Thorax 1993; 48: 827-830.
11. Tettersell MJ. Asthma patients' knowledge in relation to compliance with drug therapy. J Adv Nurs 1993; 18: 103-113.
12. Johansson G, Stallberg B, Tornling G et al. Asthma treatment preference study: a conjoint analysis of preferred drug treatments. Chest 2004; 125: 916-923.
13. Hansson SM, Lowhagen O. Drug compliance and identity: reasons for non-compliance. Experiences of medication from persons with asthma/ allergy. Patient Educ Couns 2004; 54: 3-9.
14. van Grunsven PM, van Schayck CP, van Kollenburg HJ et al. The role of "fear of corticosteroids" in nonparticipation in early intervention with inhaled corticosteroids in asthma and COPD in general practice. Eur Respir J 1998; 11: 1178-1181.
15. Lennox AS, Osman LM, Reiter E et al. Cost effectiveness of computer tailored and non-tailored smoking cessation letters in general practice: randomised controlled trial. BMJ 2001; 322: 1396.
16. Etter JF, Humair JP, Bergman MM, Perneger TV. Development and validation of the Attitudes Towards Smoking Scale (ATS-18). Addiction 2000; 95: 613-625.
17. Horne R, Weinman J. Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res 1999; 47: 555-567.
18. van Grunsven PM, van Schayck CP, van Deuveren M, van Herwaarden CL, Akkermans RP, van Weal C. Compliance during long-term treatment with fluticasone propionate in subjects with early signs of asthma or chronic obstructive pulmonary disease (COPD): results of the Detection, Intervention, and Monitoring Program of COPD and Asthma (DIMCA) Study. J Asthma 2000; 37: 225-234.
19. Earnest MA. Explaining adherence to supplemental oxygen therapy: the patient's perspective. J Gen Intern Med 2002; 17: 749-755.
20. Conrad P. The meaning of medications: another look at compliance. Soc Sci Med 1985; 20: 29-37.
21. Osman LM, Friend JA, Legge JS, Douglas JG. Requests for repeat medication prescriptions and frequency of acute episodes in asthma patients. J Asthma 1999; 36: 449-457.
22. Jones RCM, Hyland ME, Hanney K, Erwin J. A qualitative study of compliance with medication and lifestyle modification in chronic obstructive pulmonary disease (COPD). Primary Care Respiratory Journal 2004; 13: 149-154.
23. Stockley RA, Chopra N, Rice L. Addition of salmeterol to existing treatment in patients with COPD: a 12 month study. Thorax 2006; 61: 122-128.
24. Jonasson G, Carlsen KH, Mowinckel P. Asthma drug adherence in a long term clinical trial. Arch Dis Child 2000; 83: 330-333.